Recognizing clonal hematopoiesis – diagnostic challenges and clinical relevance
Which is the best combination therapy in relapsed and refractory multiple myeloma?
How do targeted treatments for IDH1 and IDH2 mutations work in acute myeloid leukemia (AML)?
Next steps for novel treatments in multiple myeloma
What’s next for rare myelomas?